KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Other Non-Current Assets (2019 - 2025)

Historic Other Non-Current Assets for Arbutus Biopharma (ABUS) over the last 7 years, with Q3 2025 value amounting to $131000.0.

  • Arbutus Biopharma's Other Non-Current Assets changed N/A to $131000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $131000.0, marking a year-over-year change of. This contributed to the annual value of $34000.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Arbutus Biopharma's Other Non-Current Assets stood at $131000.0.
  • Over the past 5 years, Arbutus Biopharma's Other Non-Current Assets peaked at $190000.0 during Q1 2022, and registered a low of $3000.0 during Q3 2023.
  • Over the past 5 years, Arbutus Biopharma's median Other Non-Current Assets value was $62000.0 (recorded in 2023), while the average stood at $88727.3.
  • In the last 5 years, Arbutus Biopharma's Other Non-Current Assets soared by 6885.25% in 2022 and then crashed by 9820.36% in 2023.
  • Quarter analysis of 5 years shows Arbutus Biopharma's Other Non-Current Assets stood at $61000.0 in 2021, then surged by 68.85% to $103000.0 in 2022, then tumbled by 97.09% to $3000.0 in 2023, then surged by 1033.33% to $34000.0 in 2024, then skyrocketed by 285.29% to $131000.0 in 2025.
  • Its last three reported values are $131000.0 in Q3 2025, $34000.0 for Q1 2025, and $34000.0 during Q4 2024.